PDS Planning Inc Acquires 257 Shares of Cardinal Health, Inc. $CAH

PDS Planning Inc raised its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 3.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,139 shares of the company’s stock after acquiring an additional 257 shares during the quarter. PDS Planning Inc’s holdings in Cardinal Health were worth $1,199,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently made changes to their positions in the stock. NBC Securities Inc. bought a new position in Cardinal Health in the 1st quarter worth about $48,000. GAMMA Investing LLC lifted its holdings in shares of Cardinal Health by 28.4% in the first quarter. GAMMA Investing LLC now owns 7,004 shares of the company’s stock worth $965,000 after buying an additional 1,549 shares in the last quarter. Handelsbanken Fonder AB lifted its holdings in shares of Cardinal Health by 4.8% in the first quarter. Handelsbanken Fonder AB now owns 41,708 shares of the company’s stock worth $5,746,000 after buying an additional 1,925 shares in the last quarter. Assenagon Asset Management S.A. increased its holdings in Cardinal Health by 25.8% during the 1st quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company’s stock worth $1,811,000 after acquiring an additional 2,694 shares during the period. Finally, CX Institutional increased its holdings in Cardinal Health by 20.7% during the 1st quarter. CX Institutional now owns 2,722 shares of the company’s stock worth $375,000 after acquiring an additional 466 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

CAH has been the subject of a number of recent analyst reports. Wall Street Zen lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 2nd. Evercore ISI dropped their price objective on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research note on Wednesday, August 13th. Citigroup reissued a “neutral” rating and set a $170.00 price objective (up previously from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday. Finally, Robert W. Baird upped their price objective on shares of Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 13th. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $166.00.

Insider Activity at Cardinal Health

In related news, CEO Jason M. Hollar sold 35,901 shares of the stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total transaction of $5,386,586.04. Following the completion of the sale, the chief executive officer directly owned 200,000 shares in the company, valued at $30,008,000. This represents a 15.22% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Stephen M. Mason sold 41,575 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $6,187,191.50. Following the completion of the sale, the chief executive officer owned 26,085 shares of the company’s stock, valued at $3,881,969.70. The trade was a 61.45% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 271,676 shares of company stock worth $40,489,525 over the last three months. Corporate insiders own 0.12% of the company’s stock.

Cardinal Health Price Performance

Shares of CAH opened at $156.86 on Friday. The firm has a market cap of $37.27 billion, a P/E ratio of 24.32, a P/E/G ratio of 1.33 and a beta of 0.71. Cardinal Health, Inc. has a 1 year low of $106.98 and a 1 year high of $168.44. The stock has a 50 day simple moving average of $152.09 and a two-hundred day simple moving average of $151.09.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business’s quarterly revenue was up .5% on a year-over-year basis. During the same period in the previous year, the business posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is 31.63%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.